DRMA · Dermata Therapeutics, Inc.
$1.42
+0.04 (+2.90%)
At close · Aug 21
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the financial statements, which is not alleviated by management's plans.”View the 10-Q filed Aug 11, 2026
Market Cap
$5.71M
Shares
4.02M
No listed options were found for DRMA.